Clinical trials
Completed Phase 2 Sarcoma, Ewing trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| Eli Lilly and Company | 2 |
| Grupo Espanol de Investigacion en Sarcomas | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Children's National Research Institute | 1 |
| Children's Oncology Group | 1 |
| Dana-Farber Cancer Institute | 1 |
| Eisai Inc. | 1 |
| Gradalis, Inc. | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Ewing | 31 |
| Rhabdomyosarcoma | 17 |
| Sarcoma | 16 |
| Neuroblastoma | 11 |
| Osteosarcoma | 10 |
| Hepatoblastoma | 6 |
| Neuroectodermal Tumors, Primitive, Peripheral | 6 |
| Wilms Tumor | 6 |
| Ependymoma | 5 |
| Medulloblastoma | 5 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.